CHIP was founded in 1998 as the Copenhagen HIV Programme, we have since rebranded “CHIP - Centre of Excellence for Health, Immunity and Infections” reflecting that activities has broadened and includes HIV co-infections with TB and hepatitis, health systems research, research supporting earlier testing and treatment of HIV and hepatitis, development of guidelines and informing policy development as well as conducting country missions in our role as WHO Collaborating Centre.
CHIP leads international multicentre research and has activities in 35+ countries and collaborates with 250+ different research institutions. The programmes are funded by the European Commission, the European Medicines Agency (D:A:D) and NIH (INSIGHT). CHIP was centrally involved in establishing the INSIGHT network, where Jens Lundgren, currently chairs the global scientific steering committee and co-chairs the START trial addressing the strategic question of when optimally to initiate antiretroviral therapy in HIV-infected.
CHIP developed the MATCH programme - a research and quality assurance tool monitoring immerging infections in immune deficient patients.
The ability to collect large volumes of high-quality data from multiple sources, and perform hypotheses-driven research on this big data is characteristic for all our activities.